Indonesia · Delayed Price · Currency is IDR IDX:BMRI Statistics
Total Valuation
IDX:BMRI has a market cap or net worth of IDR 345.33 trillion.
| Market Cap | 345.33T |
| Enterprise Value | n/a |
Important Dates
The next estimated earnings date is Wednesday, February 3, 2027.
| Earnings Date | Feb 3, 2027 |
| Ex-Dividend Date | Sep 16, 2026 |
Share Statistics
IDX:BMRI has 93.33 billion shares outstanding. The number of shares has decreased by -0.05% in one year.
| Current Share Class | 92.85B |
| Shares Outstanding | 93.33B |
| Shares Change (YoY) | -0.05% |
| Shares Change (QoQ) | +0.13% |
| Owned by Insiders (%) | 0.10% |
| Owned by Institutions (%) | 13.94% |
| Float | 37.23B |
Valuation Ratios
The trailing PE ratio is 5.38 and the forward PE ratio is 5.77. IDX:BMRI's PEG ratio is 0.85.
| PE Ratio | 5.38 |
| Forward PE | 5.77 |
| PS Ratio | 2.47 |
| PB Ratio | 1.14 |
| P/TBV Ratio | 1.19 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | 0.85 |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 1.10 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 21.76%.
| Return on Equity (ROE) | 21.76% |
| Return on Assets (ROA) | 2.60% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 2.09% |
| Revenue Per Employee | 3.46B |
| Profits Per Employee | 1.58B |
| Employee Count | 40,465 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, IDX:BMRI has paid 15.62 trillion in taxes.
| Income Tax | 15.62T |
| Effective Tax Rate | 18.89% |
Stock Price Statistics
The stock price has decreased by -22.43% in the last 52 weeks. The beta is -0.03, so IDX:BMRI's price volatility has been lower than the market average.
| Beta (5Y) | -0.03 |
| 52-Week Price Change | -22.43% |
| 50-Day Moving Average | 4,032.20 |
| 200-Day Moving Average | 4,388.93 |
| Relative Strength Index (RSI) | 42.90 |
| Average Volume (20 Days) | 249,849,535 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, IDX:BMRI had revenue of IDR 139.84 trillion and earned 64.10 trillion in profits. Earnings per share was 687.14.
| Revenue | 139.84T |
| Gross Profit | 137.30T |
| Operating Income | 82.75T |
| Pretax Income | 82.70T |
| Net Income | 64.10T |
| EBITDA | n/a |
| EBIT | n/a |
| Earnings Per Share (EPS) | 687.14 |
Balance Sheet
The company has 213.61 trillion in cash and 334.59 trillion in debt, with a net cash position of -120,983.33 billion or -1,296.25 per share.
| Cash & Cash Equivalents | 213.61T |
| Total Debt | 334.59T |
| Net Cash | -120,983.33B |
| Net Cash Per Share | -1,296.25 |
| Equity (Book Value) | 302.80T |
| Book Value Per Share | 3,150.44 |
| Working Capital | -1,626,297.64B |
Cash Flow
In the last 12 months, operating cash flow was -294,274.06 billion and capital expenditures -4,524.42 billion, giving a free cash flow of -298,798.48 billion.
| Operating Cash Flow | -294,274.06B |
| Capital Expenditures | -4,524.42B |
| Depreciation & Amortization | n/a |
| Net Borrowing | 66.13T |
| Free Cash Flow | -298,798.48B |
| FCF Per Share | -3,201.41 |
Margins
| Gross Margin | n/a |
| Operating Margin | 59.17% |
| Pretax Margin | 59.14% |
| Profit Margin | 45.84% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 476.96, which amounts to a dividend yield of 12.89%.
| Dividend Per Share | 476.96 |
| Dividend Yield | 12.89% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 4 |
| Payout Ratio | 69.38% |
| FCF Payout Ratio | n/a |
| Buyback Yield | 0.05% |
| Shareholder Yield | 12.95% |
| Earnings Yield | 18.57% |
| FCF Yield | -86.52% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Analyst Forecast
The average price target for IDX:BMRI is 4,772.17, which is 28.98% higher than the current price. The consensus rating is "Buy".
| Price Target | 4,772.17 |
| Price Target Difference | 28.98% |
| Analyst Consensus | Buy |
| Analyst Count | 25 |
| Revenue Growth Forecast (3Y) | 3.95% |
| EPS Growth Forecast (3Y) | 5.19% |
Stock Splits
The last stock split was on April 4, 2023. It was a forward split with a ratio of 2.
| Last Split Date | Apr 4, 2023 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |